Skip to the page

Data / Form D filings / Envision Life Labs LLC

Envision Life Labs LLC: Form D filings

Envision Life Labs LLC, a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on April 9, 2024, reports an offering of no set size with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
399 Binney Street, Floor 3, Cambridge, MA, 02141
Phone
(617) 861-3831
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1974864

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 9, 2024New noticeIndefinite$00Yet to occursec.gov
Apr 24, 2023New noticeIndefinite$00Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Stephen J. PagliucaDirector
Thomas J. CahillExecutive Officer, Director
Stuart J. SchreiberDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Apr 8, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Envision Life Labs LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.